Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype–Phenotype Correlations
Journal of the American Heart Association · 16.04.2024 · 13 (8)
DOI: 10.1161/jaha.123.033287 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 16.04.2024. Verfasst von Vanessa F Schmidt und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology LMU University Hospital, LMU Munich München Germany. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Vascular Malformations. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
We aimed to correlate alterations in the rat sarcoma virus (RAS)/mitogen‐activated protein kinase pathway in vascular anomalies to the clinical phenotype for improved patient and treatment stratification. Methods and Results This retrospective multicenter cohort study included 29 patients with extracranial vascular anomalies containing mosaic pathogenic variants (PVs) in genes of the RAS/mitogen‐activated protein kinase pathway. Tissue samples were collected during invasive treatment or clinically indicated biopsies. PVs were detected by the targeted sequencing of panels of genes known to be associated with vascular anomalies, performed using DNA from affected tissue. Subgroup analyses were performed according to the affected genes with regard to phenotypic characteristics in a descriptive manner. Twenty‐five vascular malformations, 3 vascular tumors, and 1 patient with both a vascular malformation and vascular tumor presented the following distribution of PVs in genes: Kirsten rat sarcoma viral oncogene (n=10), neuroblastoma ras viral oncogene homolog (n=1), Harvey rat sarcoma viral oncogene homolog (n=5), V‐Raf murine sarcoma viral oncogene homolog B (n=8), and mitogen‐activated protein kinase kinase 1 (n=5). Patients with RAS PVs had advanced disease stages according to the Schobinger classification (stage 3–4: RAS , 9/13 versus non‐ RAS , 3/11) and more frequent progression after treatment ( RAS , 10/13 versus non‐ RAS , 2/11). Lesions with Kirsten rat sarcoma viral oncogene PVs infiltrated more tissue layers compared with the other PVs including other RAS PVs (multiple tissue layers: Kirsten rat sarcoma viral oncogene, 8/10 versus other PVs, 6/19).
Conclusions
This comparison of patients with various PVs in genes of the RAS/MAPK pathway provides potential associations with certain morphological and clinical phenotypes. RAS variants were associated with more aggressive phenotypes, generating preliminary data and hypothesis for future larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology LMU University Hospital, LMU Munich München Germany.
- Interdisziplinäres Zentrum für Gefäßanomalien (IZGA) LMU University Hospital, LMU Munich München Germany.
- Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine University Medical Center Freiburg, University of Freiburg Germany.
- Clinic and Policlinic of Radiology Martin-Luther University Halle-Wittenberg Halle (Saale) Germany.
- Department of Otorhinolaryngology Regensburg University Medical Center Regensburg Germany.
- Department of Pediatric and Adolescent Surgery Paracelsus Medical University Hospital Salzburg Austria.
ORCID-Profile: Vanessa F Schmidt, Friedrich G Kapp, Constantin Goldann, Richard Brill, Armin-Johannes Michel, Max Seidensticker, Wibke Uller, Julia Haehl, Alexandra Wagner, Annegret Holm, Denny Schanze, Melanie A Kimm, Moritz Wildgruber
Zitieren
APA
Schmidt, V. F., Kapp, F. G., Goldann, C., Huthmann, L., Cucuruz, B., Brill, R., Vielsmeier, V., Seebauer, C. T., Michel, A. J., Seidensticker, M., Uller, W., Weiß, J. B. W., Sint, A., Häberle, B., Haehl, J., Wagner, A., Cordes, J., Holm, A., Schanze, D., …, & APOLLON Investigators (2024). Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype–Phenotype Correlations. Journal of the American Heart Association, 13(8). https://doi.org/10.1161/jaha.123.033287
Vancouver
Schmidt VF, Kapp FG, Goldann C, Huthmann L, Cucuruz B, Brill R, et al. Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype–Phenotype Correlations. Journal of the American Heart Association. 2024;13(8). doi:10.1161/jaha.123.033287
BibTeX
@article{Schmidt2024,
author = {Schmidt, Vanessa F and Kapp, Friedrich G and Goldann, Constantin and Huthmann, Linda and Cucuruz, Beatrix and Brill, Richard and Vielsmeier, Veronika and Seebauer, Caroline T and Michel, Armin-Johannes and Seidensticker, Max and Uller, Wibke and Weiß, Jakob B W and Sint, Alena and Häberle, Beate and Haehl, Julia and Wagner, Alexandra and Cordes, Johanna and Holm, Annegret and Schanze, Denny and Ricke, Jens and Kimm, Melanie A and Wohlgemuth, Walter A and Zenker, Martin and Wildgruber, Moritz and APOLLON Investigators, APOLLON Investigators},
title = {Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype–Phenotype Correlations},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {8},
doi = {10.1161/jaha.123.033287}
}
EUVIMED